Allergy treatment starts with diagnosis, and diagnosis starts with Hitachi Chemical Diagnostics, Inc. (HCD). This innovative in vitro system makes accessible allergy diagnosis possible now more than ever for the medical community.
HCD’s patented panel format provides medical professionals with a viable, cost-effective, front-line approach for initial allergy consultations. Unlike the traditional approach of testing only a single allergen, HCD’s panel approach offers results for up to 36 specific IgE results from one blood draw. The objective, comprehensive report can facilitate a treatment plan that could help enable a productive, healthy lifestyle.
For patients, lab testing is more comfortable and convenient than skin testing. It is an ideal alternative when medical conditions prohibit skin testing, and patients may continue taking antihistamines or other medications.
Cost-effective instrumentation
HCD’s bench-top solution offers clinics cost-effective instrumentation that advances a new service and generates new revenue, without investing in expensive equipment and consuming precious laboratory space. The simple, three-step process and same-day results gives staff walk-away time to perform other duties; offers panel formatting; and decreases technician handling time. And it requires minimal training.
Start a conversation
Surprisingly, target clients often do not include allergists. Typical clients are primary care and internal medicine physicians, ENT’s, D.O.’s and pediatricians. Start a conversation with one today by asking how often they write prescriptions for antihistamines and decongestants, or how often they refer patients to a specialist or a local lab. Also, ask if they are looking for ways to generate new revenue. Find out if you can put together a return-on-investment analysis to determine if in-house in vitro allergy testing is right for them.
Common client objections
Some common client objection include:
- “I don’t get enough allergy patients to justify testing.”
Studies report that one in five people suffer from some form of allergy. Patients are becoming savvier and expect prompt answers.
- “I don’t see the point in testing. Hay fever is not a big deal.”
Most professional medical societies recommend the use of an objective, specific IgE diagnostic test to supplement clinical history upon initial evaluation.
Primary care physicians are on the front lines of allergy diagnosis, and it’s not always possible to refer to a specialist due to time, cost or other constraints. HCD’s test is easy to access and easy to use. HCD envisions a day when allergies no longer threaten quality of life, because they are properly detected first
Editor’s note: Sponsored by Hitachi.